Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 3, 2014, Pages 609-616

  Yang, Yuesong ^a   Safka, Katherine ^a   Graham, John J ^b   Roifman, Idan ^a   Zia, Mohammad I ^a   Wright, Graham A ^a   Balter, Meyer ^a   Dick, Alexander J ^c   Connelly, Kim A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

cardiac sarcoidosis; late gadolinium enhancement MRI; T2 measurement

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; CARDIOMYOPATHIES; COHORT ANALYSIS; DIAGNOSTIC USE; FEMALE; HEART FUNCTION TEST; HUMAN; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ADULT; CARDIOMYOPATHIES; COHORT STUDIES; FEMALE; GADOLINIUM DTPA; HEART FUNCTION TESTS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84894253971     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24196     Document Type: Article

References (39)

1. Johns CJ, Michele TM,. The clinical management of sarcoidosis: a 50-year experience at the Johns Hopkins Hospital. Medicine 1999; 78: 65-111.
2. Mihailovic-Vucinic V, Sharma OP,. Atlas of sarcoidosis: pathogenesis, diagnosis, and clinical features. London: Springer; 2005. p 25-81.
3. Lannuzzi MC, Rybicki BA, Teirstein A,. Sarcoidosis. N Engl J Med 2007; 357: 2153-2165.
4. Betensky BP, Tschabrunn CM, Zado ES, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012; 9: 884-891.
5. Vasaiwala SC, Finn C, Delpriore J, et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2009; 20: 473-476.
6. Ayyala US, Nair AP, Padilla ML,. Cardiac sarcoidosis. Clin Chest Med 2008; 29: 493-508.
7. Dubrey SW, Falk RH,. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2010; 52: 336-346.
8. Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, Maguire GP,. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci 2011; 7: 546-554.
9. Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008; 133: 1426-1435.
10. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-1690.
11. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969-1977.
12. Cheong BY, Muthupillai R, Nemeth M, et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2009; 26: 39-46.
13. Yang Y, Connelly K, Graham JJ, et al. Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI. J Magn Reson Imaging 2011; 33: 211-216.
14. Yang Y, Detsky JS, Pop M, Dick AJ, Wright GA,. Detecting clinically significant subtle myocardial damage in myocardial infarction using multi-contrast delayed enhancement MRI: correlation with whole-mount heart histology at micron-level resolution. In: Proc 17th Annual Meeting ISMRM, Honolulu; 2009: 3735.
15. Detsky JS, Stainsby JA, Vijayaraghavan R, Graham JJ, Dick AJ, Wright GA,. Inversion-recovery-prepared SSFP for cardiac-phase-resolved delayed-enhancement MRI. Magn Reson Med 2007; 58: 365-372.
16. Connelly KA, Detsky JS, Graham JJ, et al. Multicontrast late gadolinium enhancement imaging enables viability and wall motion assessment in a single acquisition with reduced scan times. J Magn Reson Imaging 2009; 30: 771-777.
17. Lagana SM, Parwani AV, Nichols LC,. Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med 2010; 134: 1039-1046.
18. Vignaux O,. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005; 184: 249-254.
19. Krauss XH, van der Wall EE, van der Laarse A, et al. Follow-up of regional myocardial T2 relaxation times in patients with myocardial infarction evaluated with magnetic resonance imaging. Eur J Radiol 1990; 11: 110-119.
20. Kim D, Jensen JH, Wu EX, Sheth SS, Brittenham GM,. Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver. Magn Reson Med 2009; 62: 300-306.
21. Zia MI, Ghugre NR, Connelly KA, et al. Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling. J Cardiovasc Magn Reson 2012; 14: 19.
22. Yang Y, Foltz WD, Graham JJ, Detsky JS, Dick AJ, Wright GA,. MRI evaluation of microvascular obstruction in experimental reperfused acute myocardial infarction using a T1 and T2 preparation pulse sequence. J Magn Reson Imaging 2007; 26: 1486-1492.
23. Yang Y, Foltz WD, Merchant N, Stainsby JA, Wright GA,. Noninvasive quantitative measurement of myocardial and whole-body oxygen consumption using MRI: initial results. Magn Reson Imaging 2009; 27: 147-154.
24. Stainsby JA, Ramanan V, Slavin GS, Wright GA,. A comparison of methods for T2-mapping of the myocardium. In: Proc 18th Annual Meeting ISMRM, Stockholm; 2010: 1293.
25. O h-Ici, D, Ridgway, JP, Kuehne, T, et al. Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment. J Cardiovasc Magn Reson 2012; 14: 22.
26. Tandri H, Daya SK, Nasir K, et al. Normal reference values for the adult right ventricle by magnetic resonance imaging. Am J Cardiol 2006; 98: 1660-1664.
27. Baughman RP, Gerson M, Bosken CH,. Right and left ventricular function at rest and with exercise in patients with sarcoidosis. Chest 1984; 85: 301-306.
28. Corte TJ, Wells AU, Nicholson AG, Hansell DM, Wort SJ,. Pulmonary hypertension in sarcoidosis: a review. Respirology 2011; 16: 69-77.
29. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006; 61: 68-74.
30. Roberts WC, McAllister HA Jr, Ferrans VJ,. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63: 86-108.
31. Pierre-Louis B, Prasad A, Frishman WH,. Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol Rev 2009; 17: 153-158.
32. Tahara N, Tahara A, Nitta Y, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010; 3: 1219-1228.
33. Matthews R, Bench T, Meng H, Franceschi D, Relan N, Brown DL,. Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and (18) F-FDG PET-CT. J Nucl Cardiol 2012; 19: 807-810.
34. Yang Y, Connelly KA, Joshi SB, et al. Myocardial infarct heterogeneity and papillary muscle involvement correlated with appropriate ICD therapy in patients with ischemic heart disease. In: Proc 20th Annual Meeting ISMRM, Melbourne; 2012: 3778.
35. Bogun F, Desjardins B, Crawford T, et al. Post-infarction ventricular arrhythmias originating in papillary muscles. J Am Coll Cardiol 2008; 51: 1794-1802.
36. Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A,. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009; 104: 571-577.
37. Ma Y, Gal A, Koss MN,. The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol 2007; 24: 150-161.
38. Loganathan R, Bilgen M, Al-Hafez B, Smirnova IV,. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging 2006; 22: 81-90.
39. Bun SS, Kober F, Jacquier A, et al. Value of in vivo T2 measurement for myocardial fibrosis assessment in diabetic mice at 11.75 T. Invest Radiol 2012; 47: 319-323.